ISTH 2021 has come to a close. Precision BioLogic and Affinity Biologicals presented several e-posters at this year's virtual event. The posters are now available on our websites:
Validation of a New Kit for the Quantitative Determination of Chromogenic Factor IX Activity
We're presenting several e-posters at the ISTH Virtual Congress July 17 to 21. Be sure to check them out during the congress and afterwards on Our Publications page:
PB0100: Validation of a New Kit for the Quantitative Determination of Chromogenic Factor IX Activity
PB0101: Comparison of a Chromogenic vs. APTT-based Factor VIII Activity Assay in the Recovery of a Pegylated Factor VIII Replacement Therapy in Plasma Samples
PB0340: The Impact of Inactive FVIII Antigen in Factor VIII Deficient Plasma on the Measurement of FVIII Inhibitors
PB0471: Comparative Recovery of FVIII Antigen with Various FVIII Therapeutic Concentrates Using an Improved 2nd Generation ELISA Kit
Abstracts are now available online at abstracts.isth.org.
Today is World Hemophilia Day—an international day to raise awareness and understanding of hemophilia and other bleeding disorders. It's held each year on April 17, birthdate of Frank Schnabel, founder of the World Federation of Hemophilia (WFH).
This year's theme is "Adapting to Change: Sustaining Care in a New World." While the past year brought a lot of changes, the resilience of the global bleeding disorders community did not waver. Precision BioLogic is proud to support and celebrate this community on World Hemophilia Day 2021 and reaffirm our commitment to developing innovative diagnostic solutions.
With our colleagues from Affinity Biologicals, we encourage everyone to learn more about hemophilia and other bleeding disorders by visiting wfh.org.
April 11-17 is National Medical Laboratory Week in Canada and April 18-24 is Medical Laboratory Professionals Week in the U.S. Precision BioLogic would like to express our appreciation for medical laboratory professionals everywhere and their many contributions to health care. Thank you for your dedication and hard work, particularly during the past year.
EAHAD 2021 is underway and runs until February 5. Precision BioLogic and Affinity Biologicals are both presenting e-posters at the virtual event. Posters are also available for viewing and download from our websites:
Laboratory Validation of CRYOcheck™ Chromogenic Factor VIII Across Multiple Coagulation Analyzers, Precision BioLogic
Improved Recognition of B-Domain Deleted FVIII in Plasma with a New Commercially Available VisuLize™ F8Plus Antigen Kit, Affinity Biologicals
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the U.S. launch of its new CRYOcheck™ Hex LA™ kit. Expansion to the U.S. follows successful launches in Canada, the European Union, Australia, and New Zealand.
CRYOcheck Hex LA is intended for use in clinical labs to aid in the detection of lupus anticoagulant (LA) in human plasma. Hex LA is an integrated (screen and confirm) assay and, as its name suggests, applies hexagonal phase phospholipids. It is the first commercially available hexagonal phase LA test available in a frozen format, allowing for fast and easy preparation. Designed to work on many common automated coagulation analyzers, Hex LA offers valuable time savings to today’s busy labs.
As we prepare to chill out, we extend wishes for a warm, relaxing holiday.
Please note, we are closed from December 23 to January 3. Our regular shipping schedule resumes when we reopen on January 4, 2021.
THSNA 2020 is underway. We're presenting three posters at this year's virtual conference:
Comparison of Hexagonal Phase Phospholipid Neutralization Assays for Lupus Anticoagulant Detection
CRYOcheck™ Chromogenic Factor VIII: A New Kit for the Determination of FVIII:C Activity
Precision BioLogic, a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor VIII assay in the U.S. This clearance follows authorizations received from regulatory authorities in Canada, the European Union, Australia, and New Zealand where the assay launched earlier this year.
Registration for the ISTH 2020 Virtual Conference, July 12 to 14, is now open and you can register for free!
We're presenting two scientific posters, which will be available on the ISTH 2020 Virtual Congress Platform starting July 12, 2020. Abstracts are now available online:
Effects of Anticoagulants and Common Interfering Substances on Four Commercially Available dRVVT Assays (Abstract Number: PB0669)
Laboratory Validation of a Novel Hexagonal Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Detection (Abstract Number: PB0675)
Registration for the ISTH 2020 Virtual Conference, July 12 to 14, is now open. With the move to an online event, you can now register for free!
We're going to miss seeing you in person but hope you'll join online.
To learn more or register, visit: www.isth2020.org
Earlier this spring, we introduced a comprehensive webinar schedule to keep you up to date on all the latest developments at Precision BioLogic.
Our next webinar is "Frozen vs. Lyophilized: The Value of Precision" on Wednesday, June 3, 2020 from 1 to 2 pm Eastern. Sign up to learn more about this and future webinars.
In recognition of Lab Week and the selfless contributions of those working to protect us, Precision BioLogic and Affinity Biologicals have donated to the Canadian Red Cross and the CDC Foundation to assist in the fight against COVID-19.
As we adjust to recent developments caused by COVID-19, the safety of our customers and our personnel is our top priority.
While we'll miss seeing our customers in the foreseeable future, we've created a comprehensive webinar schedule to keep you up to date on all the latest developments at Precision BioLogic.
The first update is in late April with events continuing throughout the spring and summer.
Today is World Hemophilia Day—an international awareness day for hemophilia and other bleeding disorders. It's held each year on April 17, date of the birthday of Frank Schnabel, founder of the World Federation of Hemophilia (WFH).
This day also helps illustrate other WFH initiatives to support the bleeding disorders community. The WFH Humanitarian Aid Program provides a range of integrated care development training programs to ensure the local infrastructure and medical expertise are available to optimize and appropriately use donated products. The Global Alliance for Progress (GAP) Program was developed to greatly increase the diagnosis and treatment of people with bleeding disorders by closing the gap in treatment of people with bleeding disorders by closing the gap in treatment between developed and developing countries.